| 01/16/2026 7:00 AM | CureVac (1809122) Filer | Form 15-12G | |
| 01/07/2026 3:15 PM | CureVac (1809122) Filer | Form S-8 POS | |
| 01/06/2026 9:25 AM | CureVac (1809122) Subject Nasdaq Stock Market LLC (1354457) Filed by | Form 25-NSE | |
| 01/06/2026 5:00 AM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/18/2025 3:16 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form SC TO-T/A | |
| 12/18/2025 3:01 PM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 12/12/2025 4:09 PM | CureVac (1809122) Subject Hothum Mathias (1918385) Filed by | Form SCHEDULE 13D/A | |
| 12/12/2025 12:40 PM | CureVac (1809122) Subject KfW (821533) Filed by | Form SCHEDULE 13D/A | |
| 12/05/2025 9:10 AM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 12/03/2025 3:50 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form SC TO-T/A | |
| 11/26/2025 3:34 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form 425 | |
Get the Latest News and Ratings for CVAC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CureVac and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/26/2025 9:10 AM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/26/2025 9:13 AM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 11/25/2025 10:28 AM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 11/24/2025 9:52 AM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 11/24/2025 8:24 AM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2025 7:00 AM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form 425 | |
| 11/12/2025 7:01 AM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form 425 | |
| 10/27/2025 5:01 AM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/22/2025 8:35 PM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 10/22/2025 4:23 PM | CureVac (1809122) Subject | Form SC 14D9/A | |
| 10/22/2025 3:27 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form SC TO-T/A | |
| 10/22/2025 3:05 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form 425 | |
| 10/22/2025 3:03 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form 425 | |
| 10/21/2025 4:00 PM | CureVac (1809122) Subject | Form SC 14D9 | |
| 10/21/2025 3:29 PM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form SC TO-T | |
| 08/13/2025 5:05 PM | CureVac (1809122) Subject GSK plc (1131399) Filed by | Form SCHEDULE 13D | |
| 08/11/2025 5:37 AM | BioNTech SE (1776985) Filed by CureVac (1809122) Subject | Form 425 | |
| 08/07/2025 7:15 PM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/01/2025 6:10 PM | CureVac (1809122) Subject KfW (821533) Filed by | Form SCHEDULE 13D/A | |
| 06/26/2025 3:00 PM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/24/2025 3:50 PM | CureVac (1809122) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2025 11:48 AM | CureVac (1809122) Subject Ramanayake Thaminda (2067275) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |